37:57
Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like
All-In Podcast
Overview
This video details Bryan Johnson's experience with 5-MeO-DMT, a powerful psychedelic, as part of his longevity research. He contrasts this with his previous psilocybin experiments, explaining how psychedelics, particularly 5-MeO-DMT, can profoundly impact the brain by dissolving the default mode network (DMN), which is associated with ego and self-rumination. Johnson discusses the potential of psychedelics for neuroplasticity, rejuvenation, and a reset of metabolic and psychological patterns, while also acknowledging the significant risks involved. The conversation expands to future longevity therapies like cell and gene therapy, and the philosophical implications of altering one's identity through such powerful interventions.
How was this?
Save this permanently with flashcards, quizzes, and AI chat
Chapters
- Bryan Johnson took 5-MeO-DMT, described as the most potent psychedelic, for a longevity experiment.
- His longevity approach prioritizes interventions with the strongest scientific evidence for effect size.
- Psychedelics were not initially considered for anti-aging but rather for mental health or ritualistic use.
- Previous research with psilocybin showed potential as a longevity therapy, leading to further exploration.
This chapter sets the stage for understanding why Johnson, a proponent of evidence-based longevity, would explore a powerful psychedelic, framing it within his systematic approach to health optimization.
Johnson's team conducted a quantified experiment with psilocybin at clinical doses as part of their longevity research.
- The 5-MeO-DMT experience is described as an overwhelming encounter with raw consciousness and intelligence, beyond visual perception.
- The onset is rapid, leading to a state where one must surrender ego, attachment, and control to avoid intense fear or a feeling of being torn apart.
- Surrendering leads to unimaginable bliss and euphoria, described as the most dynamic human experience.
- The internal monologue of the ego and the default mode network (DMN) are completely silenced, leading to hyper-awareness without self-talk.
Understanding the subjective experience of 5-MeO-DMT highlights its profound psychological impact, emphasizing the necessity of surrender and the dissolution of the ego for its potential benefits.
Johnson describes the moment of surrender as having to 'say yes so thoroughly' and release 'all attachment, all preconditions, all want, all desire,' which then opens up to bliss.
- 5-MeO-DMT and psilocybin work by dissolving or dampening the default mode network (DMN), the brain's 'engine' for constructing self and ego.
- The DMN is responsible for rumination and self-referential thought, which can become rigid and narrow with age.
- Psychedelics scramble neural traffic patterns, creating new connections and promoting neuroplasticity, akin to repositioning airports on a globe.
- This rewiring can help resolve trauma and anxiety by breaking repetitive negative thought loops.
This chapter explains the biological mechanism behind the psychological effects of psychedelics, linking brain function to the potential for mental health improvements and cognitive flexibility.
The brain is likened to a globe with airports; psychedelics scramble these 'airports' (neurons) so that traffic patterns (neural pathways) are no longer fixed, allowing for new connections.
- Psilocybin showed potential for longevity by reducing inflammation and creating a metabolic reset, improving blood glucose and the microbiome.
- 5-MeO-DMT 'annihilated' the DMN far more intensely than psilocybin, leading to a restoration of childlike wonder and excitement.
- Post-5-MeO-DMT, Johnson experienced a persistent change in his DMN, leading to more childlike reactions, less rumination, and improved interpersonal communication.
- The experience resulted in a profound sense of renewal and enhanced creativity, with a childlike openness to new experiences.
This section presents evidence and subjective reports suggesting that psychedelics, particularly 5-MeO-DMT, can offer significant rejuvenation beyond typical longevity interventions, impacting both physiological and psychological states.
Johnson describes waking up laughing in a dream, a characteristic he associates with a childlike state, and experiencing emergent excitement about his day.
- Significant risks of psychedelics include inducing psychosis, permanent functional changes, and severe psychological distress if not approached with rigor (set, setting, dose).
- Johnson's own experience suggests a profound rewiring of identity, raising questions about whether one remains the 'same' person after such an intervention.
- The potential for dramatic life changes, including abandoning previous values and responsibilities, is a recognized risk, sometimes necessitating contractual clauses in investments.
- Johnson, however, felt emboldened to work more intensely, rather than abandoning his life, but acknowledges the profound shift in perspective.
This chapter addresses the critical safety concerns and existential questions surrounding powerful psychedelics, highlighting the need for caution and responsible use while exploring the philosophical implications of identity.
An investor reportedly included a clause in deal documents preventing the founder from using psychedelics during the company's duration due to the risk of them abandoning their role.
- Beyond current interventions, Johnson is exploring next-generation therapies like cell and gene therapy, mitochondrial rejuvenation, and organoid development.
- Mitochondrial augmentation therapy involves transplanting young mitochondria, potentially sourced from family members, to combat age-related decline.
- Gene therapy, such as using plasmids to deliver genes like FoxO3, shows promise for tissue regeneration.
- Developing personalized organoids (e.g., heart, liver) from induced pluripotent stem cells allows for in-vitro testing of molecules and therapies before human application.
This section looks towards the future of longevity, showcasing cutting-edge scientific frontiers that aim to address aging at a fundamental cellular and genetic level.
Johnson plans to undergo mitochondrial transplantation using mitochondria grown from a blood draw, aiming to replace his 48-year-old mitochondria with younger ones.
- In a world of rapid change driven by AI, psychedelics might offer humans the 'psycho-flexibility' needed to adapt and keep pace.
- They can provide a profound psychological rejuvenation, restoring a youthful disposition and 'can-do' attitude that may narrow with age.
- Johnson views psychedelics as potentially complementary to other longevity therapies, offering unique benefits for mental outlook and adaptability.
- Improved health and psychological well-being, potentially facilitated by therapies like psychedelics, can lead to greater societal happiness and a more proactive, problem-solving collective attitude.
This chapter positions psychedelics not just as personal rejuvenation tools but as potentially crucial aids for human adaptation in an increasingly complex and rapidly evolving future.
Johnson suggests that psychedelics could help individuals maintain a youthful, ambitious 'can-do' attitude as they age, counteracting the natural narrowing of ambition.
Key takeaways
- 5-MeO-DMT offers a profound, albeit risky, method for dissolving the ego and ego-driven thought patterns, leading to intense euphoria and a reset of psychological states.
- The default mode network (DMN) is a key target for psychedelics, and its dissolution or dampening is linked to neuroplasticity, reduced rumination, and potential resolution of trauma.
- While psilocybin shows promise for longevity through metabolic and anti-inflammatory effects, 5-MeO-DMT appears to offer a more radical psychological rejuvenation.
- The exploration of psychedelics for longevity necessitates extreme caution due to risks of psychosis and permanent psychological alteration, requiring rigorous set, setting, and dosage protocols.
- Future longevity research is rapidly advancing into cell therapies, gene editing, and organoid technology, offering new avenues for rejuvenation beyond current interventions.
- Psychedelics may play a unique role in fostering human adaptability and psychological resilience in the face of rapid technological and societal change.
- Overall health and psychological well-being are foundational to societal progress and individual happiness, with interventions like psychedelics potentially playing a role in improving both.
Key terms
5-MeO-DMTPsychedelicsLongevityDefault Mode Network (DMN)EgoNeuroplasticityPsilocybinInduced Pluripotent Stem Cells (iPSCs)OrganoidsMitochondrial Augmentation TherapyGene TherapyPlasmids
Test your understanding
- How does 5-MeO-DMT's mechanism of action differ from psilocybin in terms of its effect on the default mode network?
- What are the primary risks associated with powerful psychedelic experiences, and how can they be mitigated?
- Explain the concept of neuroplasticity and how psychedelics are thought to induce it.
- What are some of the emerging longevity therapies discussed, such as mitochondrial augmentation and organoid development?
- How might psychedelics contribute to human adaptability in the context of rapid technological advancement and societal change?